Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Phenomenex, OncoPlex Dx

Premium

Phenomenex said that its spin-off firm, Neoteryx, has released its Mitra Microsampling Device. Intended as an alternative to conventional blood draws, the device, according to the company consistently collects 10 µL of fluid while eliminating the volumetric blood hematocrit bias typically associated with the dried blood spotting technique.


OncoPlex Dx has added a quantitative androgen receptor assay to its mass spec-based Breast Cancer Proteomic Panel.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.